Systems and Methods for Automating RNA Expression Calls in a Cancer Prediction Pipeline
Copyright © Targeted News Service 2026
2026-09-08
ALEXANDRIA, Virginia, Sept. 8 -- TEMPUS AI, INC., Chicago, Illinois has been assigned a patent (No. US 12731659 B2, initially filed May 19, 2021) developed by three inventors Joshua SK Bell, Chicago, Illinois; Catherine Igartua, Chicago, Illinois; and Joshua Drews, Downers Grove, Illinois, for "Systems and methods for automating RNA expression calls in a cancer prediction pipeline." . . .
